Elevance Health, Inc. vs Johnson & Johnson
ELV vs JNJ — side-by-side comparison from reported financials. ELV leads 5, JNJ leads 5 of 10 comparable metrics.
Elevance Health, Inc.
ELV · Healthcare
$411.70+2.68%Strained
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | ELV | JNJ |
|---|---|---|
| Price | $411.70 | $261.79 |
| Market cap | $89.3B | $631B |
| Revenue (TTM) | $201B | $97.9B |
| Revenue growth | +8.3% | +5.6% |
| Net margin | 2.5% | 21.5% |
| Free cash flow | $6.29B | $22.2B |
| Net cash (debt) | $4.43B | ($27.8B) |
| 1-year price return | +15.0% | +37.0% |
| P/E | 18.0 | 29.9 |
| P/E vs own history (cheap-side %) | 48% | 16% |
| Dividend yield | 1.68% | 2.00% |
| Return on equity | 11% | 26% |
| Altman Z-score | 1.33 | — |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 97,100 | 140,800 |
Full résumé-style profiles: ELV CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.